- Filed
- Jul 31, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Jul 24, 2025 | 415.89M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 427.65M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 422.27M sh |
| Shares Diluted restated | Q2 2025 · Jun 30, 2024 | 413.59M sh |
| Shares Diluted restated | Q2 2025 · Jun 30, 2024 | 390.96M sh |
| Stock Repurchased | Q2 2025 · Jun 30, 2025 | $75M |
| Stock Repurchased | Q2 2025 · Jun 30, 2024 | $0 |
| Capex | Q2 2025 · Jun 30, 2025 | $39M |
| Capex | Q2 2025 · Jun 30, 2024 | $44M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | $145M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | $117M |
| Long Term Debt | Q2 2025 · Jun 30, 2025 | $2.75B |
| Long Term Debt | Q2 2025 · Dec 31, 2024 | $2.75B |
| Short Term Debt | Q2 2025 · Jun 30, 2025 | $5M |
| Short Term Debt | Q2 2025 · Dec 31, 2024 | $4M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $432M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $499M |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | $3.17B |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $2.98B |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $2.95B |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | $2.84B |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $2.3B |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $2.07B |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $1.93B |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $1.89B |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $5.37B |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $5.2B |
| Current Assets | Q2 2025 · Jun 30, 2025 | $2.8B |
| Current Assets | Q2 2025 · Dec 31, 2024 | $2.66B |
| Total Assets | Q2 2025 · Jun 30, 2025 | $8.54B |
| Total Assets | Q2 2025 · Dec 31, 2024 | $8.15B |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $0.16 |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $0.24 |
| Eps Diluted restated | Q2 2025 · Jun 30, 2024 | $0.15 |
| Eps Diluted restated | Q2 2025 · Jun 30, 2024 | −$0.68 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $0.17 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $0.24 |
| Eps Basic restated | Q2 2025 · Jun 30, 2024 | $0.15 |
| Eps Basic restated | Q2 2025 · Jun 30, 2024 | −$0.68 |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $472M |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $930M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $418M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $810M |
| Net Income | Q2 2025 · Jun 30, 2025 | $77M |
| Net Income | Q2 2025 · Jun 30, 2025 | $112M |
| Net Income | Q2 2025 · Mar 31, 2025 | $35M |
| Net Income | Q2 2025 · Jun 30, 2024 | $69M |
| Net Income | Q2 2025 · Jun 30, 2024 | $114M |
| Net Income | Q2 2025 · Mar 31, 2024 | $45M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $143M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $227M |
| Operating Income | Q2 2025 · Jun 30, 2024 | $126M |
| Operating Income | Q2 2025 · Jun 30, 2024 | $226M |
| Gross Profit | Q2 2025 · Jun 30, 2025 | $615M |
| Gross Profit | Q2 2025 · Jun 30, 2025 | $1.16B |
| Gross Profit | Q2 2025 · Jun 30, 2024 | $544M |
| Gross Profit | Q2 2025 · Jun 30, 2024 | $1.04B |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $1.38B |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $2.55B |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $1.19B |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $2.3B |
| Revenue | Q2 2025 · Jun 30, 2025 | $1.99B |
| Revenue | Q2 2025 · Jun 30, 2025 | $3.71B |
| Revenue | Q2 2025 · Jun 30, 2024 | $1.73B |
| Revenue | Q2 2025 · Jun 30, 2024 | $3.33B |